Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.10.4211

Association of Leptin Receptor Lys109Arg and Gln223Arg Polymorphisms with Increased Risk of Clear Cell Renal Cell Carcinoma  

Mu, Hui-Jun (Department of Clinical Laboratory Science, Wuxi People's Hospital of Nanjing Medical University)
Zou, Jian (Department of Clinical Laboratory Science, Wuxi People's Hospital of Nanjing Medical University)
Xie, Ping (Department of Clinical Laboratory Science, Wuxi People's Hospital of Nanjing Medical University)
Xu, Zhuo-Qun (Department of Urinary Surgery, Wuxi People's Hospital of Nanjing Medical University)
Ruan, Jun (Department of Urinary Surgery, Wuxi People's Hospital of Nanjing Medical University)
Yang, Shu-Dong (Department of Pathology, Wuxi People's Hospital of Nanjing Medical University)
Yin, Ying (Department of Clinical Laboratory Science, Wuxi People's Hospital of Nanjing Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.10, 2014 , pp. 4211-4215 More about this Journal
Abstract
Background: Although roles of genetic polymorphisms of leptin receptor (LEPR) gene in several cancers have been documented, the association between polymorphisms of LEPR and clear cell renal cell carcinoma (CC-RCC) remains unknown. The aim of this study was to explore any relation. Materials and Methods: The study population consisted of 77 patients with CC-RCC and 161 healthy control subjects. Polymorphism analyses of Lys109Arg and Gln223Arg were performed by direct DNA sequencing and PCR-restriction fragment length polymorphism approaches respectively. Results: Comparisons of allelic and genotypic frequencies in Lys109Arg and Gln223Arg showed no significant difference between the cases and controls. However, when evaluating the combined genotype of Lys109Arg and Gln223Arg, risk with GG/GG was increased (OR=1.85, 95%CI=1.04-3.30) and with GA/GG or GG/GA was decreased (OR=0.07, 95%CI=0.01-0.54; OR and 95%CI of the latter could not be calculated for a value of zero). Furthermore, the G-G haplotype frequency of Lys109Arg and Gln223Arg in the cases was higher (OR=1.68; 95%CI=1.02-2.76). In contrast, the A-G and G-A haplotype frequencies in the cases were lower than those in the controls (OR=0.06; 95%CI=0.01 to 0.47; OR and 95%CI of the latter could not be calculated for a value of zero). In addition, the Lys109Arg A allele was in LD with the Gln223Arg A allele (d'=0.9399) in the CC-RCC subjects, but not in the controls. Conclusions: Our data suggest that the GG/GG combined genotype and G-G haplotype of Lys109Arg and Gln223Arg can act as evaluating factors for CC-RCC risk.
Keywords
Leptin receptor; polymorphism; clear cell renal cell carcinoma;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Wu N, Wang Y, Wang S, et al (2013). Recombinant human leptin induces growth inhibition and apoptosis in human gastric cancer MGC-803 cells. Clin Exp Med, 13, 305-14.   DOI
2 Yapijakis C, Kechagiadakis M, Nkenke E, et al (2009). Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer. J Cancer Res Clin Oncol, 135, 603-12.   DOI
3 Yuan Y, Zhang J, Cai L, et al (2013). Leptin induces cell proliferation and reduces cell apoptosis by activating c-myc in cervical cancer. Oncol Rep, 29, 2291-6.
4 Zhou W, Guo S, Gonzalez-Perez R R (2011). Leptin proangiogenic signature in breast cancer is linked to IL-1 signalling. Br J Cancer, 104, 128-37.   DOI
5 Samuel-Mendelsohn S, Inbar M, Weiss-Messer E, et al (2011). Leptin signaling and apoptotic effects in human prostate cancer cell lines. Prostate, 71, 929-45.   DOI
6 Oswal A, Yeo G (2010). Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity, 18, 221-9.   DOI
7 Paracchini V, Pedotti P, Taioli E (2005). Genetics of leptin and obesity: a HuGE review. Am J Epidemiol, 162, 101-14.   DOI
8 Ptak A, Kolaczkowska E, Gregoraszczuk E L (2013). Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells. Endocrine, 43, 394-403.   DOI
9 Shimizu H, Mori M (2001). Role of leptin and its receptor in the regulation of appetite and body fat. Nihon Rinsho, 59, 421-6 (in Japanese).
10 Stefan N, Vozarova B, Del Parigi A, et al (2002). The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism. Int J Obes Relat Metab Disord, 26, 1629-32.   DOI
11 Teras L R, Goodman M, Patel A V, et al (2009). No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev, 18, 2553-7.   DOI
12 Wang L Q, Shen W, Xu L, et al (2012). The association between polymorphisms in the leptin receptor gene and risk of breast cancer: a systematic review and pooled analysis. Breast Cancer Res Treat, 136, 231-9.   DOI
13 Wauman J, Tavernier J (2011). Leptin receptor signaling: pathways to leptin resistance. Front Biosci, 17, 2771-93.
14 Woo H Y, Park H, Ki C S, et al (2006). Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Lett, 237, 137-42.   DOI   ScienceOn
15 Kovacs G, Akhtar M, Beckwith B J, et al (1997). The Heidelberg classification of renal cell tumours. J Pathol, 183, 131-3.   DOI
16 Alegre M M, Knowles M H, Robison R A, et al (2013). Mechanics behind breast cancer prevention - focus on obesity, exercise and dietary fat. Asian Pac J Cancer Prev, 14, 2207-12.   과학기술학회마을   DOI   ScienceOn
17 Dallal C, Garte S, Ragin C, et al (2013). Plasma leptin levels, LEPR Q223R polymorphism and mammographic breast density: a cross-sectional study. Int J Biol Markers, 28, 161-7.   DOI
18 Drew J E (2012). Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin. Proc Nutr Soc, 71, 175-80.   DOI
19 Ferlay J, Shin H R, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.   DOI   ScienceOn
20 Fruhbeck G. (2006). Intracellular signalling pathways activated by leptin. Biochem J, 393, 7-20.   DOI   ScienceOn
21 Han C Z, Du L L, Jing J X, et al (2008). Associations among lipids, leptin, and leptin receptor gene Gin223Arg polymorphisms and breast cancer in China. Biol Trace Elem Res, 126, 38-48.   DOI   ScienceOn
22 Horiguchi A, Sumitomo M, Asakuma J, et al (2006a). Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J Urol, 176, 1631-5.   DOI
23 Horiguchi A, Sumitomo M, Asakuma J, et al (2006b). Leptin promotes invasiveness of murine renal cancer cells via extracellular signal-regulated kinases and rho dependent pathway. J Urol, 176, 1636-41.   DOI
24 Jarde T, Perrier S, Vasson M P, et al (2011). Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer, 47, 33-43.   DOI
25 Kim E Y, Chin, H M, Park S M, et al (2012). Susceptibility of gastric cancer according to leptin and leptin receptor gene polymorphisms in Korea. J Korean Surg Soc, 83, 7-13.   DOI
26 Li L, Gao Y, Zhang L L, et al (2008). Concomitant activation of the JAK/STAT3 and ERK1/2 signaling is involved in leptinmediated proliferation of renal cell carcinoma Caki-2 cells. Cancer Biol Ther, 7, 1787-92.   DOI
27 Li Y, Geng J, Wang Y, et al (2012). The role of leptin receptor gene polymorphisms in determining the susceptibility and prognosis of NSCLC in Chinese patients. J Cancer Res Clin Oncol, 138, 311-6.   DOI
28 Liu C L, Chang Y C, Cheng S P, et al (2007). The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology, 72, 75-81.   DOI
29 Nyante S J, Gammon M D, Kaufman J S, et al (2011). Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes. Breast Cancer Res Treat, 129, 593-606.   DOI
30 Excoffier L, Lischer H E (2010). Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour, 10, 564-7.   DOI   ScienceOn
31 Liu L, Zhong R, Wei S, et al (2013). The leptin gene family and colorectal cancer: interaction with smoking behavior and family history of cancer. PLoS One, 8, 60777.   DOI
32 Zhang Y, Proenca R, Maffei M, et al (1994). Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-32.   DOI   ScienceOn